Early Access — free while we kick the tires
EdgarHawk

Flower Johanna

Director

Director
3 filings analyzed · 1 company · Latest 2026-01-16

Companies

Company Buys Sells Direction
CrowdStrike Holdings, Inc. CRWD 0 39 Net selling

Activity

January 2026
high
Sell
3,000 shares
$1,385,820
Significance 7/10

Director Johanna Flower sold 3,000 shares ($1.4M) at CRWD on 2026-01-15, reducing holdings by 3.8%; 5 of 5 prior sales at this ticker were well-timed (90d gains followed declines).

Flower executed 14 separate sales totaling 3,000 shares for $1,385,820.00 on 2026-01-15, with prices ranging from $450.72 to $468.33 and a blended average of $461.94. This represents a 3.8% reduction in her holdings (from 79.1K to 76.1K shares), a modest but deliberate share disposition. Notably, Flower's prior trades at CRWD show a consistent pattern: all 5 of 5 prior sales at this ticker were well-timed (negative 90-day returns ranging from -3.6% to -4.4%), meaning the stock declined after each sale, validating her exit timing. Her cross-ticker track record reinforces this: 20 prior sells across all tickers averaged a 50% well-timed rate at the 90-day mark. Against this backdrop, CRWD trades at $453.88, down 3.4% over 30 days and 6.4% over 90 days, and the company posted net income of -$34.0M against $1.2B quarterly revenue. The director's latest trade timing aligns with her demonstrated pattern of exiting before weakness, not coincidental favorable-momentum positioning.

October 2025
medium
Sell
2,347 shares
$1,152,341
Significance 6/10

Director Flower Johanna sold 2,347 shares of CRWD for $1,152,341.25 across 10 transactions on 2025-10-15

Flower Johanna, a director at CrowdStrike, executed 10 separate sales totaling 2,347 shares for $1,152,341.25 on 2025-10-15, reducing her holdings by 2.9% to 79,057 shares. The sales occurred at prices ranging from $485.33 to $494.27, with a blended average of $490.98, representing a modest premium to the current price of $484.65. Notably, her prior five sales at CRWD (all on 2025-04-21) generated positive 90-day returns ranging from 20.6% to 21.9%, indicating that those sales preceded significant stock appreciation rather than declines. The company reported $1.2B in revenue with strong 29.4% annual growth but remains unprofitable with -$77.7M net income, creating a tension between operational momentum and financial performance that may warrant monitoring of how the market reprices this dynamic.

April 2025
medium
Sell
2,974 shares
$1,078,020
Significance 4/10

Director Johanna Flower sold 2,974 shares for $1,078,019.56 across 15 transactions on 2025-04-21

Johanna Flower, a CrowdStrike director, executed 15 separate sales on a single date (2025-04-21) totaling 2,974 shares (3.0K shares) for $1,078,019.56 ($1.1M), with a blended average price of $362.48 across transaction prices ranging from $356.51 to $370.23. This represents a -3.5% reduction in her holdings, leaving her with 82,875 shares (82.9K shares) post-transaction. The company is currently unprofitable (net income $-16,822,000.00 for the latest quarter) despite strong revenue growth of +29.4% year-over-year and $1,010,178,000.00 ($1.0B) in latest quarterly revenue. The transaction prices at $356.51–$370.23 compare to the current price of $368.45, which sits -19.1% below the 52-week high of $455.36. The concentrated single-day execution of multiple tranches with incremental pricing suggests a structured disposition rather than a discretionary single-block sale.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access